People · Operator
Named in public records as an officer, director or promoter · active 2012–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Synlogic, Inc. | — | Biotechnology | Series C | $186.5M | $3.3B | 2012 |
| CytomX Therapeutics, Inc. | — | Biotechnology | Series C | $143.0M | $392.9M | 2014 |
| NextCure, Inc. | — | Biotechnology | Series C | $129.9M | $113.9M | 2025 |
Elaine V. Jones at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Elaine V. Jones on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Elaine Jones | 2 | 6 |
| Peter Barrett | 1 | 18 |
| Michael Powell | 1 | 14 |
| Corey Goodman | 1 | 13 |
| Edward Mathers | 1 | 12 |
| Ed Mathers | 1 | 11 |
| Chau Khuong | 1 | 9 |
| Judith Li | 1 | 8 |
| Matthew Young | 1 | 7 |
| David Kabakoff | 1 | 7 |
| Daniel Geffken | 1 | 6 |
| Michael E. Pfau | 1 | 6 |
| Lewis Geffen | 1 | 6 |
| Alan Heeger | 1 | 5 |
| Nick Leschly | 1 | 5 |
| Evan S. Melrose | 1 | 5 |
| Paul Miller | 1 | 5 |
| Nancy Stagliano | 1 | 5 |
| Gary Wilcox | 1 | 4 |
| Corey S. Goodman | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.